Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy

CAR-T cell therapy targeting CD19

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy, covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias [Phase 1, Phase 2]

See pricing